Buchumschlag

Feasibility and safety of vitamin K antagonist monotherapy in atrial fibrillation patients undergoing transcatheter aortic valve implantation

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Geis, Nicolas (VerfasserIn) , Kiriakou, Christina (VerfasserIn) , Chorianopoulos, Emmanuel (VerfasserIn) , Pleger, Sven Torsten (VerfasserIn) , Katus, Hugo (VerfasserIn) , Bekeredjian, Raffi (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 20 April 2017
In: EuroIntervention
Year: 2017, Jahrgang: 12, Heft: 17, Pages: 2058-2066
ISSN:1969-6213
DOI:10.4244/EIJ-D-15-00259
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.4244/EIJ-D-15-00259
Verlag, kostenfrei, Volltext: https://www.pcronline.com/eurointervention/114th_issue/volume-12/number-17/338/feasibility-and-safety-of-vitamin-k-antagonist-monotherapy-in-atrial-fibrillation-patients-undergoing-transcatheter-aortic-valve-implantation.html
Volltext
Verfasserangaben:Nicolas A. Geis, MD; Christina Kiriakou; Emmanuel Chorianopoulos, MD; Sven T. Pleger, MD; Hugo A. Katus, MD; Raffi Bekeredjian, MD

MARC

LEADER 00000caa a2200000 c 4500
001 1572405333
003 DE-627
005 20220814124233.0
007 cr uuu---uuuuu
008 180426s2017 xx |||||o 00| ||eng c
024 7 |a 10.4244/EIJ-D-15-00259  |2 doi 
035 |a (DE-627)1572405333 
035 |a (DE-576)502405333 
035 |a (DE-599)BSZ502405333 
035 |a (OCoLC)1341007733 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Geis, Nicolas  |d 1980-  |e VerfasserIn  |0 (DE-588)138513988  |0 (DE-627)696681854  |0 (DE-576)307885313  |4 aut 
245 1 0 |a Feasibility and safety of vitamin K antagonist monotherapy in atrial fibrillation patients undergoing transcatheter aortic valve implantation  |c Nicolas A. Geis, MD; Christina Kiriakou; Emmanuel Chorianopoulos, MD; Sven T. Pleger, MD; Hugo A. Katus, MD; Raffi Bekeredjian, MD 
264 1 |c 20 April 2017 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 26.04.2018 
700 1 |a Kiriakou, Christina  |e VerfasserIn  |0 (DE-588)1156805929  |0 (DE-627)1019739959  |0 (DE-576)502445238  |4 aut 
700 1 |a Chorianopoulos, Emmanuel  |d 1974-  |e VerfasserIn  |0 (DE-588)122373332  |0 (DE-627)705883302  |0 (DE-576)293242550  |4 aut 
700 1 |a Pleger, Sven Torsten  |d 1973-  |e VerfasserIn  |0 (DE-588)129962473  |0 (DE-627)484985221  |0 (DE-576)297924001  |4 aut 
700 1 |a Katus, Hugo  |d 1951-  |e VerfasserIn  |0 (DE-588)108916618  |0 (DE-627)577155040  |0 (DE-576)289625076  |4 aut 
700 1 |a Bekeredjian, Raffi  |d 1972-  |e VerfasserIn  |0 (DE-588)122088271  |0 (DE-627)705767930  |0 (DE-576)293085781  |4 aut 
773 0 8 |i Enthalten in  |t EuroIntervention  |d Toulouse : [Verlag nicht ermittelbar], 2005  |g 12(2017), 17, Seite 2058-2066  |h Online-Ressource  |w (DE-627)528362127  |w (DE-600)2280344-0  |w (DE-576)34727871X  |x 1969-6213  |7 nnas  |a Feasibility and safety of vitamin K antagonist monotherapy in atrial fibrillation patients undergoing transcatheter aortic valve implantation 
773 1 8 |g volume:12  |g year:2017  |g number:17  |g pages:2058-2066  |g extent:9  |a Feasibility and safety of vitamin K antagonist monotherapy in atrial fibrillation patients undergoing transcatheter aortic valve implantation 
856 4 0 |u http://dx.doi.org/10.4244/EIJ-D-15-00259  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.pcronline.com/eurointervention/114th_issue/volume-12/number-17/338/feasibility-and-safety-of-vitamin-k-antagonist-monotherapy-in-atrial-fibrillation-patients-undergoing-transcatheter-aortic-valve-implantation.html  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180426 
993 |a Article 
994 |a 2017 
998 |g 122088271  |a Bekeredjian, Raffi  |m 122088271:Bekeredjian, Raffi  |d 910000  |d 910100  |e 910000PB122088271  |e 910100PB122088271  |k 0/910000/  |k 1/910000/910100/  |p 6  |y j 
998 |g 108916618  |a Katus, Hugo  |m 108916618:Katus, Hugo  |d 910000  |d 910100  |e 910000PK108916618  |e 910100PK108916618  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 129962473  |a Pleger, Sven Torsten  |m 129962473:Pleger, Sven Torsten  |d 910000  |d 910100  |e 910000PP129962473  |e 910100PP129962473  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 122373332  |a Chorianopoulos, Emmanuel  |m 122373332:Chorianopoulos, Emmanuel  |d 910000  |d 910100  |e 910000PC122373332  |e 910100PC122373332  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1156805929  |a Kiriakou, Christina  |m 1156805929:Kiriakou, Christina  |d 910000  |d 910100  |e 910000PK1156805929  |e 910100PK1156805929  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 138513988  |a Geis, Nicolas  |m 138513988:Geis, Nicolas  |d 910000  |d 910100  |e 910000PG138513988  |e 910100PG138513988  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1572405333  |e 3007192765 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Nicolas A. Geis, MD; Christina Kiriakou; Emmanuel Chorianopoulos, MD; Sven T. Pleger, MD; Hugo A. Katus, MD; Raffi Bekeredjian, MD"]},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"20 April 2017"}],"id":{"eki":["1572405333"],"doi":["10.4244/EIJ-D-15-00259"]},"physDesc":[{"extent":"9 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Toulouse","dateIssuedDisp":"2005-","publisher":"[Verlag nicht ermittelbar]","dateIssuedKey":"2005"}],"id":{"issn":["1969-6213"],"zdb":["2280344-0"],"eki":["528362127"]},"pubHistory":["1.2005 -"],"part":{"extent":"9","volume":"12","text":"12(2017), 17, Seite 2058-2066","pages":"2058-2066","issue":"17","year":"2017"},"titleAlt":[{"title":"EuroIntervention journal"},{"title":"EIJ"}],"disp":"Feasibility and safety of vitamin K antagonist monotherapy in atrial fibrillation patients undergoing transcatheter aortic valve implantationEuroIntervention","note":["Gesehen am 22.02.24"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"recId":"528362127","title":[{"subtitle":"EIJ ; official publication of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","title":"EuroIntervention","title_sort":"EuroIntervention"}]}],"person":[{"roleDisplay":"VerfasserIn","display":"Geis, Nicolas","role":"aut","family":"Geis","given":"Nicolas"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kiriakou, Christina","given":"Christina","family":"Kiriakou"},{"display":"Chorianopoulos, Emmanuel","roleDisplay":"VerfasserIn","role":"aut","family":"Chorianopoulos","given":"Emmanuel"},{"given":"Sven Torsten","family":"Pleger","role":"aut","display":"Pleger, Sven Torsten","roleDisplay":"VerfasserIn"},{"display":"Katus, Hugo","roleDisplay":"VerfasserIn","role":"aut","family":"Katus","given":"Hugo"},{"given":"Raffi","family":"Bekeredjian","role":"aut","roleDisplay":"VerfasserIn","display":"Bekeredjian, Raffi"}],"title":[{"title_sort":"Feasibility and safety of vitamin K antagonist monotherapy in atrial fibrillation patients undergoing transcatheter aortic valve implantation","title":"Feasibility and safety of vitamin K antagonist monotherapy in atrial fibrillation patients undergoing transcatheter aortic valve implantation"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 26.04.2018"],"language":["eng"],"recId":"1572405333"} 
SRT |a GEISNICOLAFEASIBILIT2020 

Ähnliche Einträge